Skip Navigation
Search Menu

Print This Page
Share this page: More

Clinical Trials

Clinical Trials

Clinical trials advance cancer research and are the only way to find safe and potentially more effective therapies to treat cancer. Patients who enroll in clinical trials have access to new treatments that may offer better results than standard treatment.


Breast Cancer Medical Oncologist and Co-Director of the Johns Hopkins Breast Cancer Program Dr. Vered Stearns discusses the importance of clinical trials from diagnosis through survivorship, the way they shape medical care, regulatory and ethical practices in place to ensure patient safety, and how to find out about specific clinical trials in your area. Watch Now



Recent Discoveries


  • Johns Hopkins researchers find that nitroxoline, an antibiotic commonly used around the world to treat urinary tract infections, can slow or stop the growth of human breast and bladder cancer cells by blocking the formation of new blood vessels. Read more.


  • Johns Hopkins scientists report new findings about a gene target for drug resistance, a triple-drug cocktail for triple negative breast cancer, and patients’ risk for carpal tunnel syndrome at the San Antonio Breast Cancer Symposium. Read more.
  • Johns Hopkins scientists discover that SPCA2 -- a protein found in very high levels in human breast cancer cells – both pumps calcium out of cells and also moonlights as a signal to get massive quantities of the stuff to flow in, holding the promise of a new therapeutic target for certain breast cancers. Read more.


  • Johns Hopkins scientists, one year after completing the first large-scale report sequencing breast and colon cancer genes, find a cancer “landscape” dominated by genes that each are mutated in relatively few cancers. The report suggests that less-commonly mutated genes can be grouped into clusters according to their pathways. Read more.


  • Johns Hopkins scientists complete the first draft of the genetic code for breast and colon cancers.  Their report identifies close to 200 mutated genes linked to these cancers, most of which were not previously recognized as associated with tumor initiation, growth, spread or control.
  • Johns Hopkins scientists find that a method they developed to screen body fluids for certain kinds of cells and some of their genetic blueprint is twice as accurate at spotting breast cancer cells as a pathologist’s view with a microscope.Read more.

Read Our Blogs
Cancer Matters: timely topics
Our Cancer: for caregivers